Sharma, K <br/><br/>
Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.  [electronic resource] 

 -  Molecular endocrinology (Baltimore, Md.)  Dec 1996 
 - 1688-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0888-8809 
<br/><br/><label>Standard No.: </label>10.1210/mend.10.12.8961277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Apoptosis--drug effects<br/>CHO Cells--drug effects<br/>Cell Cycle--drug effects<br/>Cricetinae<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--drug effects<br/>GTP-Binding Proteins--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Hormones<br/>Humans<br/>Octreotide--pharmacology<br/>Proto-Oncogene Proteins--drug effects<br/>Proto-Oncogene Proteins c-bcl-2<br/>Proto-Oncogene Proteins c-myc--drug effects<br/>Receptors, Somatostatin--genetics<br/>Signal Transduction<br/>Tumor Suppressor Protein p53--drug effects<br/>bcl-2-Associated X Protein